EFTA01385522
EFTA01385523 DataSet-10
EFTA01385524

EFTA01385523.pdf

DataSet-10 1 page 350 words document
P21 V15
Open PDF directly ↗ View extracted text
📄 Extracted Text (350 words)
> Energy, Materials & Industrials Gil Deutsche Bank DSM - Virginie Boucher-Ferte, BUY, close €81.8, €100 tgt, 22% potential upside • We see Nutrition (68% of EBITDA) as a key growth driver. We forecast a DSM Nutrition organic growth now compares well to peers 9% EBITDA 2018-20E CAGR driven by cost cutting, innovation and leverage of its broad portfolio. 10% DSM Nutntion organic growth - A greater proportion of the Nutrition portfolio is in higher-value and faster-growing ingredients and 'solutions' rather than just vitamins. 9% • — — Food Ingredients organic growth average 8% 7% • • Up to 30% upside to 18E EBITDA forecast if vitamin price increases are 6% sustained. 5% 4% I - Prices are unlikely to revert fully: China's environmental policies are 3% should give structural support in the long term. 2% 1% ■ Full exit from Materials likely, driving portfolio shift towards becoming a 0% pure play in higher-value ingredients. 2009 2010 2011 2012 2013 2014 2015 2016 2017E Source: Deutsche Bank. Company Data ■ M&A should drive the next phase of development. DSM is likely to use its strong balance sheet (0.5x 17E net debt/EBITDA) to broaden its ingredients portfolio. Lots of firepower for accretive M &A (DBe synergies 6% of sales) - This would unlock >E20/share of value from EPS accretion and re- 3000 Net Debt (LHS) —Net Deb/EBITDA (RHS) 2.50 rating. 2500 - 2.00 • Trades on 16x 19E PIE, in line with chems but a 33% discount to 2000 15 1.50 ingredients. We believe the portfolio shift should prompt re-rating. 1.00 ■ Our €100 tgt implies a 20x 19E PIE — still a 15% discount to ingredients. 1000 0.50 • Catalysts: Upside through higher value and fast growing ingredients and 500 - "solutions". Portfolio shift optionality. 0.00 Related DB Research: -500 -0.50 ()SPA: The path to E100 (and potentially more): upgrade to BUY (Boucher-Fenel 2007 2009 2011 2013 2015 2017E 2019E nI gredients: 2018 Outlook: Recipe for successi_Boucher-Fertel Source: DIPUISCI10 Bank, Company Data :),,ean Equity Focus -January 2018 CONFIDENTIAL - PURSUANT TO FED. R. GRIM. P. 6(e) DB-SDNY-0086809 CONFIDENTIAL SDNY_GM_00232993 EFTA01385523
ℹ️ Document Details
SHA-256
b7fb5e576f252b1c17fdaccee5437b10289c5a4dd71b18020dd39560dfc40361
Bates Number
EFTA01385523
Dataset
DataSet-10
Document Type
document
Pages
1
Link copied!